Siemens Healthineers announced today the launch of the company's Technology Optimization Partnerships at the Association for the Advancement of Medical Instrumentation (AAMI) eXchange event in San Antonio, TX. Technology Optimization Partnerships are a strategic approach to multivendor service that leverage connected solutions to help hospitals and health systems make data-driven decisions, improve equipment utilization, and enhance financial performance across the enterprise.
The innovative approach to service delivers a multitude of key benefits including efficient standardized service for all medical technology regardless of manufacturer; quality and performance assurance that maximizes technology uptime; and a single point of contact that simplifies technology management and accountability. By going beyond the traditional service model with optional connected offerings, such as RealTime Location Solutions (RTLS), medical device cybersecurity, remote scanning technology, and ongoing workforce development, Technology Optimization Partnerships can help hospitals and health systems enhance the performance of their medical technology fleet and reach key institutional goals.
"We are extremely excited about our new Technology Optimization Partnerships," said Brent Kruse, Senior Vice President & Head of Enterprise Services (Americas). "By partnering with Siemens Healthineers beyond traditional technology management, healthcare organizations will now have the potential to transform their service department from a cost center to a growth center."
About Siemens Healthineers
Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company's foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers' ability to provide high-quality, efficient care. In fiscal 2021, which ended on September 30, 2021, Siemens Healthineers, which has approximately 66,000 employees worldwide, generated revenue of €18.0 billion and adjusted EBIT of €3.1 billion. Back to HCB News